Our previous study and emerging experimental data have already demonstrated that mTOR signaling pathway played a central role in the activation of hepatic stellate cells, moreover, the pathway blockade by rapamycin could reverse liver fibrosis, improve liver function, and lower portal pressure in established cirrhotic animal models [12–15]. Here, MTOR is linked to Hepatic fibrosis.